Advertisement

Daniel Sullivan, MD, Honored for Leadership in Quantitative Imaging Biomarkers


Advertisement
Get Permission

The Prevent Cancer Foundation recently honored Daniel C. Sullivan, MD, with the James L. Mulshine, MD Leadership Award for his work in founding and chairing the Quantitative Imaging Biomarkers Alliance (QIBA). The Quantitative Imaging Biomarkers Alliance is committed to attempting to transform patient care by making the field of radiology a more quantitative science.

As part of the Radiological Society of North America, the Quantitative Imaging Biomarkers Alliance is the leading international organization working to standardize the use of imaging biomarkers in research and clinical practice across 28 different imaging platforms. The goal is to develop comprehensive quality measures to reduce measurement differences between various hardware and software components used in quantitative medical imaging. Standardizing the performance steps for all professional groups involved in using imaging to measure disease progression is critical to ensuring the reliability of quantitative imaging methods in clinical decision-making.

“QIBA is a remarkable international organization working to integrate emerging advanced medical imaging into useful tools to advance care for all,” said James L. Mulshine, MD, Scientific Director of the Prevent Cancer Foundation, for whom the award is named. “Thanks to his sustained and gracious efforts in nurturing the development of QIBA, as well as his leadership efforts in imaging development at the National Cancer Institute [NCI], Dr. Sullivan is broadly acknowledged as making extraordinary contributions to medical innovation.”

Dr. Sullivan has both clinical and research expertise in nuclear medicine and oncologic imaging, with a focus on improving the use of imaging as a biomarker in clinical trials and clinical practice. He completed his radiology residency and nuclear medicine fellowship in 1977 at Yale New Haven Hospital. Dr. Sullivan has held faculty appointments at Yale University Medical Center, Duke University Medical Center, and the University of Pennsylvania Medical Center.

In addition, Dr. Sullivan joined the NCI in 1997. Until 2007, Dr. Sullivan served as Associate Director in the Division of Cancer Treatment and Diagnosis and Head of the Cancer Imaging Program. 


Advertisement

Advertisement



Advertisement